IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greed Is Good who wrote (193)	12/21/1997 1:02:00 PM
From: Mark B. Martell, CCM	of 1510

Gentlepersons, My guess why the stock has gone down is some recent profit taking and "buying on rumor, selling on news". Like myself. I bought IMNR back in March hoping for a run up through November based on Remune's progress. The company seemed to point us towards November for commercial viability of Remune. The stock had run from $6-8 to $11-14 per share on this hope. When the stock got to $13 and IMNR told us that Remune was 7 months away (May) from having a more definitive view of Remune's success, it appeared to me to be a good time for some profit taking. Hopefully they won't strike some sort of licensing deal before the mid/end first quarter so that I can buy back in before the next run up through May. I'll be watching this one closely. I see great things in the pipeline with this company...... Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next